Literature DB >> 3531231

Rapid diagnosis of severe Haemophilus influenzae serotype b infections by monoclonal antibody enzyme immunoassay for outer membrane proteins.

A Belmaaza, J Hamel, S Mousseau, S Montplaisir, B R Brodeur.   

Abstract

A highly sensitive and specific enzyme immunoassay (EIA) for the detection of Haemophilus influenzae serotype b antigens in body fluids and broth cultures was developed, with a polyclonal antibody directed against polyribose phosphate as the solid-phase reagent and a biotinylated monoclonal antibody directed against H. influenzae type b outer membrane protein as the liquid-phase reagent. H. influenzae type b antigens could be detected in broth cultures containing as little as 50 organisms per ml. The sensitivity and specificity of this system were compared with those of two commercial kits and counterimmunoelectrophoresis. The overall detection of H. influenzae type b antigens in clinical specimens collected from children infected with H. influenzae type b was as follows: with Phadebact, 86 and 86% in cerebrospinal fluid and urine specimens, respectively; with Bactigen, 86, 80, and 92%, with counterimmunoelectrophoresis, 78, 73, and 75%, and with biotin-avidin EIA, 100, 100, and 100% for cerebrospinal fluid, serum, and urine specimens, respectively. In the biotin-avidin EIA, no positive reactions were noted in specimens collected from patients infected with other bacteria or from patients without evidence of bacterial infection, whereas false-positive reactions were found by counterimmunoelectrophoresis and the commercial kits. These results suggest that this monoclonal antibody reacting with the outer membrane protein is more specific and sensitive than the conventional methods using polyclonal antisera for the detection of H. influenzae type b antigens during severe infections in children.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3531231      PMCID: PMC268930          DOI: 10.1128/jcm.24.3.440-445.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Relation of concentrations of bacteria and bacterial antigen in cerebrospinal fluid to prognosis in patients with bacterial meningitis.

Authors:  W E Feldman
Journal:  N Engl J Med       Date:  1977-02-24       Impact factor: 91.245

2.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

3.  Detection of bacterial antigen in pleural fluid by counterimmunoelectrophoresis.

Authors:  R M Lampe; T Chottipitayasunondh; P Sunakorn
Journal:  J Pediatr       Date:  1976-04       Impact factor: 4.406

4.  Insolubilized biotin for the purification of avidin.

Authors:  E Bayer; M Wilchek
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

5.  Latex agglutination test for the diagnosis of Haemophilus influenzae meningitis.

Authors:  R B Newman; R W Stevens; H A Gaafar
Journal:  J Lab Clin Med       Date:  1970-07

6.  [Rapid diagnosis of bacterial infections by counter-immunoelectrophoresis].

Authors:  S Montplaisir; J Bahous
Journal:  Union Med Can       Date:  1977-10

7.  Detection of Haemophilus influenzae type b antigens in body fluids, using specific antibody-coated staphylococci.

Authors:  M Suksanong; A S Dajani
Journal:  J Clin Microbiol       Date:  1977-01       Impact factor: 5.948

8.  An Escherichia coli antigen cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b: occurrence among known serotypes, and immunochemical and biologic properties of E. coli antisera toward H. influenzae type b.

Authors:  R Schneerson; M Bradshaw; J K Whisnant; R L Myerowitz; J C Parke; J B Robbins
Journal:  J Immunol       Date:  1972-06       Impact factor: 5.422

9.  Counterimmunoelectrophoresis in the diagnosis of bacterial meningitis.

Authors:  H Colding; I Lind
Journal:  J Clin Microbiol       Date:  1977-04       Impact factor: 5.948

10.  Protection against infection with Neisseria meningitidis group B serotype 2b by passive immunization with serotype-specific monoclonal antibody.

Authors:  B R Brodeur; Y Larose; P Tsang; J Hamel; F Ashton; A Ryan
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

View more
  4 in total

Review 1.  Pertussis: the disease and new diagnostic methods.

Authors:  R L Friedman
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

2.  Monoclonal antibodies for clinical applications. Patents and literature.

Authors:  J S Dordick
Journal:  Appl Biochem Biotechnol       Date:  1988-12       Impact factor: 2.926

3.  Identification of Haemophilus influenzae type b by a monoclonal antibody coagglutination assay.

Authors:  J Hamel; B R Brodeur; A Belmaaza; S Montplaisir; J M Musser; R K Selander
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

Review 4.  Clinical laboratory applications of monoclonal antibodies.

Authors:  W J Payne; D L Marshall; R K Shockley; W J Martin
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.